Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Obstetrical & Gynecological Survey|August 22, 2014
Metformin and gynecologic cancersJessica E Stine, Victoria Bae-JumpObstetrical & Gynecological Survey|August 8, 2014
A comprehensive review of diagnostic and treatment options for granulosa cell tumors of the ovaryJessica E Stine, Stuart Pierce, John T SoperObstetrical & Gynecological Survey|August 13, 2014
Uterine morcellation at the time of hysterectomy: techniques, risks, and recommendationsJessica E Stine, Daniel L Clarke-Pearson, Paola A GehrigGynecologic Oncology|June 1, 2014
Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancerMonica N Schointuch, Timothy P Gilliam, Jessica E Stine, et al.Oncotarget|October 28, 2015
The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancerJessica E Stine, Hui Guo, Xiugui Sheng, et al.Endocrine-Related Cancer|June 6, 2015
Glutamine promotes ovarian cancer cell proliferation through the mTOR/S6 pathwayLingqin Yuan, Xiugui Sheng, Adam K Willson, et al.Journal of Hematology & Oncology|January 30, 2015
Evaluation of the anti-tumor effects of lactate dehydrogenase inhibitor galloflavin in endometrial cancer cellsXiaoyun Han, Xiugui Sheng, Hannah M Jones, et al.Gynecologic Oncology|January 8, 2017
Prior breast cancer and tamoxifen exposure does not influence outcomes in women with uterine papillary serous carcinomaStuart R Pierce, Jessica E Stine, Paola A Gehrig, et al.American Journal of Cancer Research|January 10, 2018
Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer <i>in vitro</i>Hannah M Jones, Ziwei Fang, Wenchuan Sun, et al.American Journal of Cancer Research|June 12, 2018
Erratum: Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer <i>in vitro</i>Hannah M Jones, Ziwei Fang, Wenchuan Sun, et al.Pageof 2